Current and historical daily PE Ratio for ABCZF (
Abcam PLC
) from 2010 to May 23 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Abcam PLC stock (ABCZF) PE ratio as of May 23 2024 is 1483.33.
More Details
Abcam PLC (ABCZF) PE Ratio (TTM) Chart
Abcam PLC (ABCZF) PE Ratio (TTM) Historical Data
View and export this data going back to 2010. Start your Free Trial
Total 1233
- 1
- 2
- 3
- 4
- 5
- 6
- 14
| Abcam PLC PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-05-23 | NaN | 2024-03-20 | NaN |
| 2024-05-22 | NaN | 2024-03-19 | NaN |
| 2024-05-21 | NaN | 2024-03-18 | NaN |
| 2024-05-20 | NaN | 2024-03-15 | NaN |
| 2024-05-17 | NaN | 2024-03-14 | NaN |
| 2024-05-16 | NaN | 2024-03-13 | NaN |
| 2024-05-15 | NaN | 2024-03-12 | NaN |
| 2024-05-14 | NaN | 2024-03-11 | NaN |
| 2024-05-13 | NaN | 2024-03-08 | NaN |
| 2024-05-10 | NaN | 2024-03-07 | NaN |
| 2024-05-09 | NaN | 2024-03-06 | NaN |
| 2024-05-08 | NaN | 2024-03-05 | NaN |
| 2024-05-07 | NaN | 2024-03-04 | NaN |
| 2024-05-06 | NaN | 2024-03-01 | NaN |
| 2024-05-03 | NaN | 2024-02-29 | NaN |
| 2024-05-02 | NaN | 2024-02-28 | NaN |
| 2024-05-01 | NaN | 2024-02-27 | NaN |
| 2024-04-30 | NaN | 2024-02-26 | NaN |
| 2024-04-29 | NaN | 2024-02-23 | NaN |
| 2024-04-26 | NaN | 2024-02-22 | NaN |
| 2024-04-25 | NaN | 2024-02-21 | NaN |
| 2024-04-24 | NaN | 2024-02-20 | NaN |
| 2024-04-23 | NaN | 2024-02-16 | NaN |
| 2024-04-22 | NaN | 2024-02-15 | NaN |
| 2024-04-19 | NaN | 2024-02-14 | NaN |
| 2024-04-18 | NaN | 2024-02-13 | NaN |
| 2024-04-17 | NaN | 2024-02-12 | NaN |
| 2024-04-16 | NaN | 2024-02-09 | NaN |
| 2024-04-15 | NaN | 2024-02-08 | NaN |
| 2024-04-12 | NaN | 2024-02-07 | NaN |
| 2024-04-11 | NaN | 2024-02-06 | NaN |
| 2024-04-10 | NaN | 2024-02-05 | NaN |
| 2024-04-09 | NaN | 2024-02-02 | NaN |
| 2024-04-08 | NaN | 2024-02-01 | NaN |
| 2024-04-05 | NaN | 2024-01-31 | NaN |
| 2024-04-04 | NaN | 2024-01-30 | NaN |
| 2024-04-03 | NaN | 2024-01-29 | NaN |
| 2024-04-02 | NaN | 2024-01-26 | NaN |
| 2024-04-01 | NaN | 2024-01-25 | NaN |
| 2024-03-28 | NaN | 2024-01-24 | NaN |
| 2024-03-27 | NaN | 2024-01-23 | NaN |
| 2024-03-26 | NaN | 2024-01-22 | NaN |
| 2024-03-25 | NaN | 2024-01-19 | NaN |
| 2024-03-22 | NaN | 2024-01-18 | NaN |
| 2024-03-21 | NaN | 2024-01-17 | NaN |
Abcam PLC (ABCZF) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Abcam PLC
ISIN : GB00B6774699
Share Class Description:
ABCZF: Ordinary SharesDescription
Abcam PLC is a biotechnology company that develops and provides antibodies to life science research and clinical communities. The company's products allow research into the role of signaling and regulatory molecules and proteins in biological pathways. Such research ultimately leads to treatments for diseases such as cancer and immune deficiency disorders. Abcam's focused on broadening its product range, improving speed to market, and accessing underpenetrated consumer groups in its markets. The company also selectively pursues partnerships and acquisitions.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers